Skip to main content

Saint Louis University Header Logo Center

Menu Search & Directory

Research Innovation Group

The Research Innovation Group (RIG) manages the intellectual property portfolio and industry contracting activities for Saint Louis University.

RIG’s mission is to increase the adoption and dissemination of SLU research discoveries and intellectual properties and to leverage SLU research and innovation assets to benefit the community. Our goal is to become exceptional at technology transfer and industry engagement as well as a partner of choice for research and intellectual property commercialization.

RIG’s main office is located in CIC@4240 in the heart of the Cortex Innovation Community to better connect with industry and integrate SLU within the region’s innovation and entrepreneurship ecosystem. The Cortex Innovation Community was founded in 2002 through a collaboration among SLU, Washington University in Saint Louis, University of Missouri – St. Louis, BJC Healthcare, and the Missouri Botanical Garden. It is the Midwest’s premier innovation hub for research, development, and commercialization in biosciences and technology. Cortex anchors the St. Louis region’s growing innovation ecosystem for startups and established companies.

For SLU Students

The Research Innovation Group at Saint Louis University offers support and encouragement to student entrepreneurship, innovation, and research excellence in a variety of ways. All current students are very welcome to contact us if you have any questions.

MedLaunch

MEDLaunch is a non-profit biomedical and entrepreneurship incubator partnering with Saint Louis University and other organizations in the Saint Louis area. The goal of MedLaunch is to improve the standard of healthcare through the engineering and design of creative solutions while also fostering a community of entrepreneurship and collaboration at Saint Louis University.

Visit the MedLaunch Website

For Community Stakeholders

The Research Innovation Group at Saint Louis University is committed to leveraging our research and innovation assets for the benefit of our community. We strive to generate real impact in tackling social and scientific challenges facing our society through partnerships and programs.

The September 2017 Reinventing Research Commercialization Conference

The Research Innovation Group is committed to developing and implementing new approaches to technology transfer. It knows these will be needed to bring transformative discoveries resulting from university research more quickly and effectively to market. To this end, in September 2017, the Research Innovation Group brought together national leaders in technology transfer, regional innovators, entrepreneurs, business managers and advisors at the "Reinventing Research Commercialization Conference" to participate in this reinvention process.

The presentations from this conference are available below.

 

Search Intellectual Property Portfolio

Use the directory below to browse and search our intellectual property portfolio to identify technologies that may be of interest to you.

ID Intellectual Property Type
ID Intellectual Property Type
98-013 NK3.3 Human Natural Killer Cell Line Derived from Healthy Male Research Tool
03-016 Studying Oncolytic Adenovirus Vectors Using a Syrian Hamster Model Research Tool
03-017 Studying Oncolytic Adenovirus Vectors Using a Cotton Rat Model Research Tool
06-013 Treating Metabolic Disorders in a Fetus Therapeutic
06-047 Treating Immune System Mediated Diseases Using TAT-BH3 Therapeutic
07-023 Minimizing Risks and Complicaitons Assocated with Retinal Detachment Surgery Medical Device
10-001 Improving Weather-Influenced Decisions Using Environmental Predictive Analytics Industrial Application
10-010 Developing an Antiviral Vaccine for Herepes Simplex Virus by Encoding Co-stimumlation Molecules Therapeutic
10-014 Improving Robotic Systems for Brain Surgery Using a Self-Opening Distractor Medical Device
10-015 Improving Operating Room Procedures Using a Finger-based Data Input Device Medical Device
10-017 Detecting DNA and RNA Using Biolayer Interferometry with Ultra-High Sensitivity Diagnostic
10-018 Preventing and Treating Influenza Using Peptides to Induce Heterosubtypic Influenza T Cell Responses Therapeutic
10-019 Assessing the Language Proficiency of Individuals Using Crowdsourced Examinations Industrial Application
11-010 Studying Chronic Liver Disease Using a PiZ Transgenic Mouse Model of a1At Mutant Z Liver Injury Research Tool
11-015 Novel Approach for Treating Cancer Using Adenovirus E1A Fragments Drug Delivery
11-027 Treating Cornelia de Lange Syndrome Using Indomethacin-based Drugs Therapeutic
12-013 Preventing Bone Loss by Regulating FOXP3+CD8 T Cells Therapeutic
12-014 Treating Malaria Using Aminohydantoin Compounds Therapeutic
13-014 Microfluidic Device Systems and Methods for Fabrication Industrial Application
14-011 Treating Bone Loss Using Low Dose RANKL Therapy Therapeutic
14-013 Delivering Bioactive Components Using a Hydorlytically Degradable Polyethylene Glycol Microsphere Drug Delivery
14-017 Diagnosing and Treating Endometriosis-related Infertility Therapeutic
14-018 Novel Therapuetic Strategy for Treating Human Breast Cancer Regulating SALL1 Functions Therapeutic
15-012 Producting Biomaterial Platforms for Researching Cell Substrate Relationships Industrial Application
15-014 Treating Cancers, Neurodegenerative Diseases, and Other Rare Conditions Using MUB LBL and LBL-based Peptides Drug Delivery
15-015 Suppressing Tumors Using MCPIP1 Therapeutic
15-026 Improve Tissue Healing Using a Honey-eluting Cryogel for Tissue Engineering Drug Delivery
15-027 Producing a Biocompatible and Biodegradeable Silk Fibroin Cryogel for Use in Tissue Engineering Drug Delivery
15-032 Promoting Nerve Repair Using Neural Tissue Engineering Method of Transferring Single-Walled Carbon Nanotubes on a Hydrogel Drug Delivery
16-006 Integrating 3-Dimensional Cell Culture Scaffolds in Microfludic Devices Industrial Application
16-011 Preventing and Treating Infections Caused by Herpersviridae Using Mutant Herpes Simplex Virus Therapeutic
16-018 Producing Nanomaterials Using Mask-free Production Methods Industrial Application
16-022 Treating Osteogenesis Imperfecta Using Pulsed Low-Dose RANKL Therapeutic
16-025 Blue Fluorescent Molecules for Organic Light Emitting Diodes Industrial Application
17-002 Novel Antibiotic Candidates Based on Inhibitors of Nucleotidyltransferase Superfamily Enzymes Therapeutic
17-003 Deriving Photoinduced Ring Closure From Dinaphthothiphenes Industrial Application
17-004 Treating Cancers and Infectious Diseases Using NK3.3-Derived Extracellular Vesicles Therapeutic
17-006 Curbing Estgrogen Promoted Cancel Cell Proliferation Using Indole-2-Carboxamide Deraviatives Therapeutic
17-007 Measuring GPER Agonism, Antagonism, and Inverse Agonism Using a Novel High-Throughput Screening Assay Diagnostic
17-008 Maintaining GALNS Enzyme Activity for Extended Periods Using an Injectable Hydrogel Depot Drug Delivery
17-010 Regenerating Tissue Using an Aligned Electrospun Matrix of Decellularized Muscle Therapeutic
17-013 Treating Atherosclerosis by Induction of TcREG Therapeutic
17-015 Treating Short Gut Syndrome and Preventing Necrotizing Enterocolitis Using Fatty Acid Conjugated Epidermal Growth Factor Variants Therapeutic
17-017 Treating Facioscapulohumeral Muscular Dystrophy (FSHD) Using P38 Inhibitors Therapeutic
17-018 Minimizing the Collection Time for Hemotopoietic Stem Cells Using Novel VLA4 Antagonist Compounds Drug Delivery
17-019 Minimizing the Collection Time for Hemotopoietic Stem Cells Using Novel VLA4 Antagonist Compounds Drug Delivery
17-024 Measuring the Efficiency of Efflux Pumps in Bacterial Strains and Permeability Properties of Bacterial Cell Envelopes Using a Molecular Fluorescent Ruler Diagnostic
17-025 Repairing and Regenerating Tissue Using Biomimetic Sponges Therapeutic
17-026 Treating Muscle Dysfunction Using ERR Ligands Therapeutic
17-033 Treating Malaria Using Pyrrolidine Compounds Therapeutic
17-034 Assessing Biofilm Infections Using a Novel Bacterial Biofilm Assay Diagnostic
17-036 Treating Malaria Using Pyrrolidine Compounds Therapeutic
17-037 Dibenzothiophene Sulfone Cell Dyes Research Tool
17-038 Detecting Hemoglobin C in Environments that Lack Modern Infrastructure Using a Method Based on Induction of Intracellular HbC Cyrstals Diagnostic
17-039 Treating Cancer Using Novel Molecules for Photodynamic Therapy Drug Delivery
17-040 Improving Cognitive Function in Aging-related Dementia Using Adropun Peptides Therapeutic
17-041 Treating Atherosclerosis by Induction of Regulaory CD8T Cells Therapeutic
18-003 Treating Cancer Using Synthesis of a Molecule that Undergoes S-O Bond Cleavage to Produce a Toxic Compound Therapeutic
18-006 Performing Multiple PCR-based Laboratory Developed Tests Simultaneously Using a Common PCR Platform System Research Tool
18-007 Preventing Traumatic Brain Injury Induced Cognitive Impairment Using Adenosine 3A Subtype Agonists Therapeutic
18-008 Preventing Chemotherapy-induced Cognitive Impairment Using Adensoine 3A Subtype Agonists Therapeutic
18-010 Studying the Role of GPER in Various Diseases Using Novel GPER Agonists Research Tool
18-012 Developing Better Treatments for Resistant Cancers Using Novel Small Molecule Inhibitors of the Human RECQ1 Helicase Drug Delivery
18-013 Eliminating Bacterial Biofilms Using a Phytochemcial Therapeutic
18-017 Treating Facioscapulohumeral Muscular Dystrophy (FSHD) Using P38 Beta-selective Inhibitors Therapeutic
18-018 Developing Treatments for Hematological Disorders Caused by B19V Infection Using Small Molecule Compounds That Directly Inhibit B19V Replication Drug Delivery
18-020 Treating Zika Virus Using Selective Estrogen Modulators Therapeutic
18-022 Studying the Role of REV-ERBa in Cardiac Hypertrophy and Heart Failure Research Tool
18-023 Treating Facioscapulohumeral Muscular Dystrophy (FSHD) Using Pyrrolopyridinone Compounds that Inhibit BET Bromodomains Therapeutic
18-024 Improving the Consistency of Image-guided Head and Neck Radiotherapy Delivery Using an Auto-adaptable Head Rest Medical Device
18-025 Improving the Data Quality of Echocardiograms Using 2D, 3D, and 4D Technology Medical Device
18-026 Generating Atomic Oxygen Using Visible Light Drug Delivery
18-027 Treating Hepatitis B Virus Infection Using Alpha-Hydroxytropolones as Inhibitors of HBV Replication Therapeutic
18-028 Improving Large-Scale Study of Proteins Using Mass Spectropscopy with Isotope Labeling Research Tool
18-029 Treating Pain Accompanying Irritable Bowel Syndrome Using Adenosine 3A Receptor Subtype Agonist Therapeutic